Young adults with autism may show abnormalities in the activity of dopamine transporters — proteins that recycle dopamine after its…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
GEN Pharmaceuticals has received ethical approval from an accredited medical research ethics committee in the Netherlands to conduct a…
Casma Therapeutics has been awarded $7.6 million from The Michael J. Fox Foundation (MJFF) to support the preclinical…
The integration of Kneu Health’s smartphone-based platform into Cedars-Sinai’s Parkinson’s care program enabled ongoing symptom monitoring and revealed the…
Immunis said it entered into an exclusive deal with Toray for the rights to develop and commercialize a…
Oncodesign Precision Medicine (OPM) has been awarded a $6.92 million research grant from The Michael J. Fox Foundation (MJFF)…
Japan’s Ministry of Health, Labour and Welfare has granted conditional approval to Amchepry, Sumitomo Pharma’s stem cell-derived therapy designed…
A fully implanted brain device can identify when people with Parkinson’s disease are walking during their everyday lives, according…
The Silvi Foundation has officially launched as a nonprofit organization dedicated to advancing research into Parkinson’s disease and…
The Parkinson’s Foundation has released its new national strategy dedicated to improving care for people with Parkinson’s disease…